Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Journal of Virology
|
June 3, 2026
Human parainfluenza virus 3 fusion protein cleavage: a key determinant of infection and spread
Kyle Stearns, Tara Marcink, Emily Pawlack, et al.
Nature Communications
|
October 12, 2024
How a paramyxovirus fusion/entry complex adapts to escape a neutralizing antibody
Tara C Marcink, Gillian Zipursky, Elizabeth B Sobolik, et al.
Emerging Infectious Diseases
|
March 6, 2023
Genomic Characterization of Respiratory Syncytial Virus during 2022-23 Outbreak, Washington, USA
Stephanie Goya, Jaydee Sereewit, Daniel Pfalmer, et al.
Journal of Virology
|
January 15, 2026
Impact of mutations affecting 4'-fluorouridine susceptibility on fitness and treatment outcomes for Venezuelan equine encephalitis virus
Jenny Wong, Tahirah Moore, Devin Lewis, et al.
Journal of Virology
|
August 7, 2025
A luminescent attenuated SARS-CoV-2 for the identification and validation of drug-resistant mutants
Yao Ma, Chengjin Ye, Ahmed Magdy Khalil, et al.
Biorxiv : the Preprint Server for Biology
|
June 4, 2025
A luminescent attenuated SARS-CoV-2 for the identification and validation of drug-resistant mutants
Yao Ma, Chengjin Ye, Ahmed Magdy Khalil, et al.
Plos Pathogens
|
February 1, 2024
Influenza A virus resistance to 4'-fluorouridine coincides with viral attenuation in vitro and in vivo
Carolin M Lieber, Hae-Ji Kang, Megha Aggarwal, et al.
Mbio
|
April 14, 2026
A fusion protein's weak link: functional constraints revealed by inhibitory peptide interaction with the parainfluenza fusion protein
Maximilian Crosby, Ariel J Kuhn, Gillian Zipursky, et al.
Biorxiv : the Preprint Server for Biology
|
October 31, 2023
Influenza A virus resistance to 4'-fluorouridine coincides with viral attenuation <i>in vitro</i> and <i>in vivo</i>
Carolin M Lieber, Hae-Ji Kang, Megha Aggarwal, et al.
Nature Communications
|
February 12, 2026
Development of a potent monoclonal antibody for treatment of human metapneumovirus infections
Evelyn D Harris, Morgan McGovern, Sara Pernikoff, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Journal of Virology
|
June 3, 2026
Human parainfluenza virus 3 fusion protein cleavage: a key determinant of infection and spread
Kyle Stearns, Tara Marcink, Emily Pawlack, et al.
Nature Communications
|
October 12, 2024
How a paramyxovirus fusion/entry complex adapts to escape a neutralizing antibody
Tara C Marcink, Gillian Zipursky, Elizabeth B Sobolik, et al.
Emerging Infectious Diseases
|
March 6, 2023
Genomic Characterization of Respiratory Syncytial Virus during 2022-23 Outbreak, Washington, USA
Stephanie Goya, Jaydee Sereewit, Daniel Pfalmer, et al.
Journal of Virology
|
January 15, 2026
Impact of mutations affecting 4'-fluorouridine susceptibility on fitness and treatment outcomes for Venezuelan equine encephalitis virus
Jenny Wong, Tahirah Moore, Devin Lewis, et al.
Journal of Virology
|
August 7, 2025
A luminescent attenuated SARS-CoV-2 for the identification and validation of drug-resistant mutants
Yao Ma, Chengjin Ye, Ahmed Magdy Khalil, et al.
Biorxiv : the Preprint Server for Biology
|
June 4, 2025
A luminescent attenuated SARS-CoV-2 for the identification and validation of drug-resistant mutants
Yao Ma, Chengjin Ye, Ahmed Magdy Khalil, et al.
Plos Pathogens
|
February 1, 2024
Influenza A virus resistance to 4'-fluorouridine coincides with viral attenuation in vitro and in vivo
Carolin M Lieber, Hae-Ji Kang, Megha Aggarwal, et al.
Mbio
|
April 14, 2026
A fusion protein's weak link: functional constraints revealed by inhibitory peptide interaction with the parainfluenza fusion protein
Maximilian Crosby, Ariel J Kuhn, Gillian Zipursky, et al.
Biorxiv : the Preprint Server for Biology
|
October 31, 2023
Influenza A virus resistance to 4'-fluorouridine coincides with viral attenuation <i>in vitro</i> and <i>in vivo</i>
Carolin M Lieber, Hae-Ji Kang, Megha Aggarwal, et al.
Nature Communications
|
February 12, 2026
Development of a potent monoclonal antibody for treatment of human metapneumovirus infections
Evelyn D Harris, Morgan McGovern, Sara Pernikoff, et al.
Page
of 2